Fig. 1From: Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancerSummary of patients and samples for sequencing. AÂ Outline of samples available for exome sequencing from PDAC and chronic pancreatitis (CP) control cases. BÂ Clinical timelines including survival and treatment periods for sequenced PDAC patients. 5FU, 5-Fluorouracil; CAP, Capecitabine; Chemorad, Chemoradiation; GEM, GemcitabineBack to article page